Androgenetic alopecia form of alopecia and it begins mostly after the beginning of puberty. Androgenetic alopecia is caused owing to excessive response of androgens, and various genetic factors. The National Center for Biotechnology Information mentioned that androgenetic alopecia affects at least 50% of males and females worldwide. It is distinguished by loss of terminal hair, in males the hair loss takes place in the frontotemporal regions and the vertex, while in females it takes place in the anterior part sparing the frontal hairline.
Key players are focusing on research and development activities, which is estimated to propel the growth of the global androgenetic alopecia treatment market during the forecast period. For instance, Histogen Inc., declared the completion of their clinical trial of HST-001. This drug is designed for examining the tolerability, efficacy and safety of HST-001 for treating androgenic alopecia in men.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/4316
Impact of COVID-19-
COVID-19 was initially reported in 2019, in China and later on spread around the world, affecting almost 100 nations. It was declared as a public health emergency by the World Health Organization. A report by the WHO suggested that COVID-19 has COVID-19 has affected more than 64.9 million infected individuals globally.
COVID-19 has directly affected the economy and has impacted the demand and production of goods in various sectors, it has also disrupted the distribution channels and has affected the financial markets around the world. Many countries like Saudi Arabia, UAE, Egypt and a few others are facing challenges in transportation of drugs due to disruptions in the transport system due to lockdown being imposed in various countries.
Furthermore, the pandemic has also affected supply chains of raw materials, which are required for manufacturing the drugs used in treating androgenetic alopecia, it is estimated to hinder the growth of the global androgenetic alopecia treatment market.
Key players are focusing on research and development activities for treating androgenetic alopecia. For instance, Aclaris Therapeutics, Inc., announced that they have received positive results from the Phase II clinical trials of ATI-502, a Janus Kinase (JAK) 1/3 inhibitor, tested on patients of androgenetic alopecia.
Increasing incidences of androgenetic alopecia is anticipated to witness growth and exhibit a CAGR of 5.2% in the global androgenetic alopecia treatment market over the forecast period. For instance, the American Society of Hair Loss Association, published an article in 2015 stating that almost 40% of women and 70% of men have been affected by androgenic alopecia in their lifetime.
Moreover, due to the effective product offering by the manufacturers, the topical agents segment, amongst drug type is expected to witness growth in the global androgenetic alopecia treatment market over the forecast period. For instance, Johnson & Johnson has been marketing Minoxidil, for hair regrowth in men and women with androgenetic alopecia and it has been approved by the regulatory authorities.
Furthermore, owing to its effectiveness in the prevention and treatment, the topical segment, among route of administration, is expected to propel growth of the global androgenetic alopecia treatment market over the forecast period. For instance, the National Center for Biotechnology Information, published an article in in August 2019, stating that topical minoxidil is the main backbone in the treatment for androgenetic alopecia, as it improves hair growth an also reduces loss of hair by affecting follicular cells.
Increasing incidences of androgenetic alopecia in males is estimated to boost the growth of the male segment, among gender in the global androgenetic alopecia treatment market over the forecast period. For instance, the American Hair Loss Association mentions that, 2/3 of American men will experience some amount of hair loss by the age of 35 and by the age of 50, 85% men are expected to experience hair thinning.
Rising partnerships and agreements between pharmacies service providers and hospitals is anticipated to witness growth in the hospital pharmacies segment, amongst distribution channel, of the global androgenetic alopecia treatment market during the forecast period.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/4316
Key players active in the global androgenetic alopecia treatment market are Cipla Limited, Ranbaxy Laboratories Ltd, Aclaris Therapeutics, Inc., Vitabiotics, Histogen Inc., Johnson and Johnson Services, Inc., Dr. Reddy’s Laboratories, Merck & Co., Inc., Vita-Cos-Med Klett-Loch GmbH, Daiichi-Sankyo Co., Ltd., Lexington International LLC and Follica, Inc.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Androgenetic Alopecia Treatment Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Androgenetic Alopecia Treatment Industry Impact
Chapter 2 Global Androgenetic Alopecia Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Androgenetic Alopecia Treatment (Volume and Value) by Type
2.3 Global Androgenetic Alopecia Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Androgenetic Alopecia Treatment Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Androgenetic Alopecia Treatment Market Analysis
Chapter 6 East Asia Androgenetic Alopecia Treatment Market Analysis
Chapter 7 Europe Androgenetic Alopecia Treatment Market Analysis
Chapter 8 South Asia Androgenetic Alopecia Treatment Market Analysis
Chapter 9 Southeast Asia Androgenetic Alopecia Treatment Market Analysis
Chapter 10 Middle East Androgenetic Alopecia Treatment Market Analysis
Chapter 11 Africa Androgenetic Alopecia Treatment Market Analysis
Chapter 12 Oceania Androgenetic Alopecia Treatment Market Analysis
Chapter 13 South America Androgenetic Alopecia Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Androgenetic Alopecia Treatment Business
Chapter 15 Global Androgenetic Alopecia Treatment Market Forecast (2022-2028)
Chapter 16 Conclusions
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/4316
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027